Innate Pharma SA
PAR:IPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
PAR:IPH
|
FR |
|
IndoSterling Technomedia Tbk PT
IDX:TECH
|
ID |
|
Fincantieri SpA
MIL:FCT
|
IT |
|
Funkwerk AG
F:FEW
|
DE |
|
H
|
Huntwicke Capital Group Inc
OTC:HCGI
|
US |
|
M
|
M Pictures Entertainment PCL
SET:MPIC
|
TH |
|
Morphic Holding Inc
NASDAQ:MORF
|
US |
|
H
|
HAL Trust
OTC:HALFF
|
MC |
|
B
|
Bee Vectoring Technologies International Inc
CNSX:BEE
|
CA |
|
HAL Trust
AEX:HAL
|
MC |
|
Loop Industries Inc
NASDAQ:LOOP
|
CA |
|
FlexShopper Inc
NASDAQ:FPAY
|
US |
|
G
|
G-Able PCL
SET:GABLE
|
TH |
|
Environmental Clean Technologies Ltd
ASX:ECT
|
AU |
Shareholder Yield
Current shareholder yield for IPH is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
IPH Price
Innate Pharma SA
| Average Annual Return | -5.1% |
| Standard Deviation of Annual Returns | 38.32% |
| Max Drawdown | -85% |
| Market Capitalization | 175.8m EUR |
| Shares Outstanding | 93 920 000 |
| Percentage of Shares Shorted |
N/A
|
